Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
All the volumes indicated here are working volumes unless specified. The total bioreactor volume needs to be at least 20Â % higher than the working volume; that is, a bioreactor with 20,000Â L working volume has a 25,000Â L total volume.
Abbreviations
- CHO:
-
Chinese Hamster Ovary
- BHK:
-
Baby Hamster Kidney
- cGMP:
-
Current Good Manufacturing Practices
- DO:
-
Dissolved Oxygen
- WFI:
-
Water for Injection
- HVAC:
-
Heating, Ventilation, and Air Conditioning
- QC:
-
Quality Control
- RTD:
-
Resistance Temperature Detector
References
Ozturk SS, Hu Wei-Shou (2006) Cell culture technology for pharmaceutical and cell-based therapies. CRC Press, Taylor & Francis Group, Boca Raton
Kelley B (2009) Industrialization of mAb production technology: the bioprocess industry at a crossroads. mAbs 1:443–452
Shukla AA, Thömmes J (2012) Recent advances in large-scale production of monoclonal antibodies and related proteins. Trends Biotechnol 28(5):253–261
Werner A (2010) Biopharmaceutical manufacturing trends for maximizing antibody yields. In: European Association of Pharma Biotechnology (EAPB), Vienna. Accessed 24–25 February 2010
Ransohoff TC, Ecker DM, Levine HL, Miller J (2008) Cell culture manufacturing capacity: trends and outlook through 2013. PharmSource Information Services, Springfield, VA
Nelson K (2006) Facility design. In: Ozturk SS, Hu W-S (eds) Cell culture technology for pharmaceutical and cell-based therapies. CRC Press, Taylor & Francis Group, Boca Raton
Jayapal KP, Wlaschin KF, Hu W-S, Yap MGS (2007) Recombinant protein therapeutics from CHO cells-20 years and counting. Chem Eng Prog 103:40–47
Farid SS (2007) Process economics of industrial monoclonal antibody manufacture. J Chromatogr B 848:8–18
Birch JR, Racher JR (2006) Antibody production. Adv Drug Delivery Rev 58:671–685
Li F, Vijayasankaran N, Shen A, Kiss R, Amanullah A (2010) Cell culture processes for monoclonal antibody production. mAbs 2(5):466–477.
Seth G, Hamilton RW, Stapp TR, Zheng L, Meier A, Petty K, Leung S, Chary S (2013) Development of a new bioprocess scheme using frozen seed train intermediates to initiate CHO cell culture manufacturing campaigns. Biotechnol Bioeng 110:1376–1385
Freshney RI (2010) Culture of animal cells, 6th edn. Wiley, Hoboken
Eibl D, Peuker T, Eibl R (2010) Single-use equipment in biopharmaceutical manufacture: a brief introduction. In: Eibl R, Eibl D (eds) Single-use technology in biopharmaceutical manufacture. Wiley, Hoboken, pp 145–148
Fenge C, Lüllau E (2006) Cell culture bioreactors. In: Ozturk SS, Hu WS (eds) Cell culture technology for pharmaceutical and cell-based therapies. CRC Press, Taylor & Francis Group, Boca Raton
Bonham-Carter J, Shevitz J (2011) A brief history of perfusion biomanufacturing: how high-concentration cultures will characterize the factory of the future. BioProcess Int 9(9):24–31
Ozturk SS (2008) Towards more modular, compact, and cost effective manufacturing facilities: combining the latest advances in process development with bioreactor technology development. In: IBC’s BioProcess international conference & exhibition, Anaheim, CA. Accessed 23–26 Sept 2008
Andersen DC, Reilly DE (2004) Production technologies for monoclonal antibodies and their fragments. Curr Opin Biotechnol 15:456–462
Ozturk SS, Kompala D (2006) Optimization of high cell density perfusion Cultures. In: Ozturk SS, Hu W-S (eds) Cell culture technology for pharmaceutical and cell-based therapies. CRC Press, Taylor & Francis Group, Boca Raton
Ozturk SS (1996) Engineering challenges in high density cell culture bioreactors. Cytotechnology 22:3–16
Nienow AW (2010) Impeller selection for animal cell culture. Encyclopedia of industrial biotechnology: bioprocess, bioseparation, and cell technology. Wiley, New York
Ozturk SS, Palsson BO (1990) Effects of dissolved oxygen on hybridoma cell growth, metabolism and antibody production kinetics in continuous cultures. Biotechnol Prog 6:437–446
Jorjani P, Ozturk SS (1999) Effects of cell density and temperature on oxygen consumption rate for different mammalian cell lines. Biotechnol Bioeng 64(3):349–356 (Aug 5)
Godoy-Silva R, Berdugo C, Chalmers JJ (2010) Aeration, mixing, and hydrodynamics, animal cell bioreactors. In: Flickinger MC (ed) Encyclopedia of industrial biotechnology: bioprocess, bioseparation, and cell technology. Wiley, Hoboken
Ma N, Chalmers JJ, Aunins JG, Zhou W, Xie L (2004) Quantitative studies of cell-bubble interactions and cell damage at different pluronic F-68 and cell concentrations. Biotechnol Prog 20(4):1183–1191
Ozturk SS (2006) Design and implementation of large scale stirred-tank bioreactors. In: BioProduction international conference, Dublin, Republic of Ireland
Eibl R, Kaiser S, Lombriser R, Eibl D (2010) Disposable bioreactors: the current state-of-the-art and recommended applications in biotechnology. Appl Microbiol Biotechnol 86(1):41–49
Shukla AA, Gottschalk U (2012) Single-use disposable technologies for biopharmaceutical manufacturing. Trends Biotechnol 31(3):147–154
Acknowledgments
I would like to thank Dr. Mark Leney and Dr. Roger Anderson for the review of the chapter and for their valuable comments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ozturk, S.S. (2013). Equipment for Large-Scale Mammalian Cell Culture. In: Zhou, W., Kantardjieff, A. (eds) Mammalian Cell Cultures for Biologics Manufacturing. Advances in Biochemical Engineering/Biotechnology, vol 139. Springer, Berlin, Heidelberg. https://doi.org/10.1007/10_2013_259
Download citation
DOI: https://doi.org/10.1007/10_2013_259
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-54049-3
Online ISBN: 978-3-642-54050-9
eBook Packages: Chemistry and Materials ScienceChemistry and Material Science (R0)